Centers for Disease Control and Prevention - ERA

Description

The purpose of this project is to evaluate the feasibility of initiating antiretroviral therapy (ART) in persons diagnosed with acute or early HIV infection. We propose a prospective study of innovative approaches for initiating ART in persons diagnosed with acute or early HIV infection within days of their diagnosis. The primary outcomes of interest will be time to viral suppression and the proportion of patients who remain virally suppressed 12 months after diagnosis. Additional outcomes may include retention in HIV care, patient satisfaction with clinical care, changes in HIV transmission risk behavior, an evaluation of laboratory markers of viral suppression, and other outcomes as determined by patient input and the study investigators.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• Others

Contact

Paul Smutz<br/>POS1@cdc.gov<br/>
POS1@cdc.gov